ZANZIMI Trademark

Trademark Overview


On Tuesday, October 8, 2019, a trademark application was filed for ZANZIMI with the United States Patent and Trademark Office. The USPTO has given the ZANZIMI trademark a serial number of 79272955. The federal status of this trademark filing is REGISTERED as of Tuesday, May 5, 2020. This trademark is owned by Glaxo Group Limited. The ZANZIMI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
zanzimi

General Information


Serial Number79272955
Word MarkZANZIMI
Filing DateTuesday, October 8, 2019
Status700 - REGISTERED
Status DateTuesday, May 5, 2020
Registration Number6044748
Registration DateTuesday, May 5, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 18, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 2, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Sunday, July 30, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, July 24, 2020NOTIFICATION PROCESSED BY IB
Thursday, July 9, 2020FINAL DISPOSITION NOTICE SENT TO IB
Thursday, July 9, 2020FINAL DISPOSITION PROCESSED
Thursday, June 4, 2020GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, May 5, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, February 18, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 29, 2020NOTICE OF PUBLICATION
Tuesday, January 14, 2020ASSIGNED TO LIE
Monday, January 13, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 13, 2020ASSIGNED TO EXAMINER
Friday, December 6, 2019APPLICATION FILING RECEIPT MAILED
Monday, December 2, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 29, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, November 28, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB